Brennan David R
- SEC CIK
- 0001609305
In the past year, 1 open-market sale filing worth $3.10M and no purchases.
Current role at each company
- INSM INSMED IncDirectoras of Sep 11, 2026
- ALXN Alexion Pharmaceuticals, Inc.Directoras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.10M
- 1 filing
- Net
- −$3.10M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Brennan David R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INSM INSMED Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Brennan David RDirector | PPurchase | +10.0K | $30.15 | +$301.5K | +14.1%80.9K after | |
| Sep 11, 2026 (view filing)4:04 PM ET | Sep 9 | 2 days | Brennan David RDirector | SSale | −25.0K | $124.00 | −$3.10M | −38.9%39.2K after |